Gilead Sciences Inc. (NASDAQ:GILD) shares slipped in Tuesday’s extended trading after the company released its fourth-quarter earnings report with weak fiscal 2026 guidance.
Here’s a look at the key figures from the quarter.
- GILD stock is moving. Watch the price action here.
The Details: Gilead reported quarterly earnings of $1.86 per share, which beat the consensus estimate of $1.81, according to data from Benzinga Pro.
Quarterly revenue came in at $7.93 billion, which beat the Street estimate of $7.69 billion.
The company reports the following fourth quarter metrics:
- Liver Disease portfolio sales increased 17% to $844 …